CN1899529A - Chinese medicine for treating chronic virus hepatitis B and its producing method - Google Patents
Chinese medicine for treating chronic virus hepatitis B and its producing method Download PDFInfo
- Publication number
- CN1899529A CN1899529A CNA200610010241XA CN200610010241A CN1899529A CN 1899529 A CN1899529 A CN 1899529A CN A200610010241X A CNA200610010241X A CN A200610010241XA CN 200610010241 A CN200610010241 A CN 200610010241A CN 1899529 A CN1899529 A CN 1899529A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- rhizoma
- herba
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine for treating chronic viral hepatitis B is prepared with capillary artemisia, herba patriniae, gentian root, cogongrass rhizome, white peony root and other 18 kinds of Chinese medicinal materials in certain weight proportion and through special processing. The synergistic effects of the medicine materials make the Chinese medicine possess functions of clearing away heat, promoting diuresis, treating jaundice, soothing the liver and invigorating spleen. The Chinese medicine has high clinical curative effect.
Description
(1) technical field
What the present invention relates to is a kind of medicine, specifically a kind of with the treatment chronic viral hepatitis B Chinese medicine preparation.The invention still further relates to the manufacture method of the Chinese medicine preparation of this treatment chronic viral hepatitis B.
(2) background technology
At present the treatment of hepatitis B is not still had specific medicine, Therapeutic Method and the medicine that adopts comprises usually: 1, hepatic, and the effect that in fact " protects the liver " treatment waits discussion, and liver is vulnerable to the infringement of medicine.2, antiviral drugs, as interferon etc., its curative effect is relatively poor, and side effect is big, after the drug withdrawal and easily bounce-back, and the drug price costliness, treatment cost height.
(3) summary of the invention
The object of the invention is to provide a kind of Chinese medicine that chronic viral hepatitis B is had the chronic viral hepatitis B of excellent curative.The present invention also aims to provide the manufacture method of this Chinese medicine.
The object of the present invention is achieved like this: per 1000 parts of products are by Herba Artemisiae Scopariae 30-60 part, Herba Patriniae 25-50 part, Radix Gentianae 20-40 part, Rhizoma Imperatae 20-40 part, Radix Paeoniae Alba 20-40 part, Radix Et Rhizoma Rhei 20-40 part, Herba Ecliptae 15-30 part, Radix Achyranthis Bidentatae 15-30 part, Radix Angelicae Sinensis 20-40 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Rhizoma Curcumae 15-30 part, Radix Codonopsis 20-40 part, Carapax Trionycis 15-30 part, Radix Astragali 30-60 part, Fructus Crataegi 20-40 part, Squama Manis 10-20 part, Pericarpium Citri Reticulatae 20-40 part, Radix Bupleuri 15-30 part, Poria 15-30 part, Herba Taraxaci 20-40 part, Rhizoma Polygonati 20-40 part, Radix Glycyrrhizae 15-30 part and SHANZHIZI 20-40 part are made.
Product of the present invention is to adopt such method to make: according to per 1000 parts of product Herba Artemisiae Scopariae 30-60 parts, Herba Patriniae 25-50 part, Radix Gentianae 20-40 part, Rhizoma Imperatae 20-40 part, Radix Paeoniae Alba 20-40 part, Radix Et Rhizoma Rhei 20-40 part, Herba Ecliptae 15-30 part, Radix Achyranthis Bidentatae 15-30 part, Radix Angelicae Sinensis 20-40 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Rhizoma Curcumae 15-30 part, Radix Codonopsis 20-40 part, Carapax Trionycis 15-30 part, Radix Astragali 30-60 part, Fructus Crataegi 20-40 part, Squama Manis 10-20 part, Pericarpium Citri Reticulatae 20-40 part, Radix Bupleuri 15-30 part, Poria 15-30 part, Herba Taraxaci 20-40 part, Rhizoma Polygonati 20-40 part, the ratio of Radix Glycyrrhizae 15-30 part and SHANZHIZI 20-40 part is got raw material ready; To decoct with water 2 times after Herba Artemisiae Scopariae, Herba Patriniae, Radix Gentianae, SHANZHIZI, Rhizoma Polygonati and the Rhizoma Imperatae mixing, decocting time is 2 hours, 1.5 hours for the second time for the first time, and twice resulting decoction liquor merged, and is condensed into extractum; With wearing into smalls after Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Rhizoma Curcumae, Radix Et Rhizoma Rhei, Radix Codonopsis, the Radix Astragali, Radix Bupleuri, Squama Manis, Carapax Trionycis and the Radix Glycyrrhizae mixing, to mix with the resulting extractum of previous step then, dry back is being ground into fine powder; Herba Ecliptae, the Rhizoma Atractylodis Macrocephalae, Fructus Crataegi, Herba Taraxaci, the Radix Paeoniae Alba, Pericarpium Citri Reticulatae and Poria are decocted with water 2 times, produce behind the concentrated solution to mix according to the manufacture method of pill and make pill with resulting fine powder of last step.
Herba Artemisiae Scopariae among the present invention, Herba Patriniae, Radix Gentianae, Fructus Gardeniae, Radix Et Rhizoma Rhei, Radix Glycyrrhizae have the effect of eliminating damp-heat, jaundice eliminating; The Radix Astragali, the Rhizoma Atractylodis Macrocephalae, the Radix Paeoniae Alba, Fructus Crataegi, Pericarpium Citri Reticulatae, Radix Bupleuri, Poria, Rhizoma Imperatae have the effect of the liver soothing and the spleen invigorating dampness removing; Radix Codonopsis, Radix Angelicae Sinensis, Rhizoma Polygonati, Herba Ecliptae, Radix Achyranthis Bidentatae, Rhizoma Curcumae, Herba Taraxaci have the effect of QI invigorating nourishing YIN, heat-clearing and toxic substances removing; Carapax Trionycis, Squama Manis have the effect of hard masses softening and resolving, the liver benefiting.The present invention cooperatively interacts these medicines, each composition is coordinated mutually, be processed into product of the present invention through special, has heat-clearing and dampness-resolving, the effect of the liver soothing and the spleen invigorating the liver benefiting, " first wood hepatitis B concentrated pill " made according to prescription of the present invention through preliminary clinical verification determined curative effect, and effective percentage 97.5% invalidly accounts for 2.5%.
(4) specific embodiment
For a more detailed description to the present invention for example below:
According to per 1000 parts of product Herba Artemisiae Scopariae 30-60 parts, Herba Patriniae 25-50 part, Radix Gentianae 20-40 part, Rhizoma Imperatae 20-40 part, Radix Paeoniae Alba 20-40 part, Radix Et Rhizoma Rhei 20-40 part, Herba Ecliptae 15-30 part, Radix Achyranthis Bidentatae 15-30 part, Radix Angelicae Sinensis 20-40 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Rhizoma Curcumae 15-30 part, Radix Codonopsis 20-40 part, Carapax Trionycis 15-30 part, Radix Astragali 30-60 part, Fructus Crataegi 20-40 part, Squama Manis 10-20 part, Pericarpium Citri Reticulatae 20-40 part, Radix Bupleuri 15-30 part, Poria 15-30 part, Herba Taraxaci 20-40 part, Rhizoma Polygonati 20-40 part, the ratio of Radix Glycyrrhizae 15-30 part and SHANZHIZI 20-40 part is got raw material ready; To decoct with water 2 times after Herba Artemisiae Scopariae, Herba Patriniae, Radix Gentianae, SHANZHIZI, Rhizoma Polygonati and the Rhizoma Imperatae mixing, decocting time is 2 hours, 1.5 hours for the second time for the first time, and twice resulting decoction liquor merged, and is condensed into extractum; With wearing into smalls after Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Rhizoma Curcumae, Radix Et Rhizoma Rhei, Radix Codonopsis, the Radix Astragali, Radix Bupleuri, Squama Manis, Carapax Trionycis and the Radix Glycyrrhizae mixing, to mix with the resulting extractum of previous step then, dry back is being ground into fine powder; Herba Ecliptae, the Rhizoma Atractylodis Macrocephalae, Fructus Crataegi, Herba Taraxaci, the Radix Paeoniae Alba, Pericarpium Citri Reticulatae and Poria are decocted with water 2 times, produce behind the concentrated solution to mix according to the manufacture method of pill and make pill with resulting fine powder of last step.
Get raw material according to per 1000 parts of products ready by the ratio of 30 parts of 40 parts of Herba Artemisiae Scopariaes, 30 parts of Herba Patriniae, 30 parts of Radix Gentianaes, 30 parts of Rhizoma Imperataes, 30 parts of the Radix Paeoniae Albas, 30 parts of Radix Et Rhizoma Rhei, 20 parts of Herba Ecliptaes, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Radix Angelicae Sinensis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Rhizoma Curcumae, 30 parts of Radix Codonopsis, 20 parts of Carapax Trionycis, 50 parts of the Radixs Astragali, 30 parts of Fructus Crataegis, 15 parts of Squama Maniss, 30 parts of Pericarpium Citri Reticulataes, 20 parts of Radix Bupleuri, 20 parts in Poria, 30 parts of Herba Taraxaci, 30 parts of Rhizoma Polygonatis, 20 parts in Radix Glycyrrhizae and SHANZHIZI; To decoct with water 2 times after Herba Artemisiae Scopariae, Herba Patriniae, Radix Gentianae, SHANZHIZI, Rhizoma Polygonati and the Rhizoma Imperatae mixing, decocting time is 2 hours, 1.5 hours for the second time for the first time, and twice resulting decoction liquor merged, and is condensed into extractum; With wearing into smalls after Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Rhizoma Curcumae, Radix Et Rhizoma Rhei, Radix Codonopsis, the Radix Astragali, Radix Bupleuri, Squama Manis, Carapax Trionycis and the Radix Glycyrrhizae mixing, to mix with the resulting extractum of previous step then, dry back is being ground into fine powder; Herba Ecliptae, the Rhizoma Atractylodis Macrocephalae, Fructus Crataegi, Herba Taraxaci, the Radix Paeoniae Alba, Pericarpium Citri Reticulatae and Poria are decocted with water 2 times, decocting time is 2 hours, 1.5 hours for the second time for the first time, twice resulting decoction liquor merged, produce behind the concentrated solution to mix according to the manufacture method of pill and make pill with resulting fine powder of last step.
Claims (3)
1, a kind of Chinese medicine for the treatment of chronic viral hepatitis B is characterized in that: per 1000 parts of products are by Herba Artemisiae Scopariae 30-60 part, Herba Patriniae 25-50 part, Radix Gentianae 20-40 part, Rhizoma Imperatae 20-40 part, Radix Paeoniae Alba 20-40 part, Radix Et Rhizoma Rhei 20-40 part, Herba Ecliptae 15-30 part, Radix Achyranthis Bidentatae 15-30 part, Radix Angelicae Sinensis 20-40 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Rhizoma Curcumae 15-30 part, Radix Codonopsis 20-40 part, Carapax Trionycis 15-30 part, Radix Astragali 30-60 part, Fructus Crataegi 20-40 part, Squama Manis 10-20 part, Pericarpium Citri Reticulatae 20-40 part, Radix Bupleuri 15-30 part, Poria 15-30 part, Herba Taraxaci 20-40 part, Rhizoma Polygonati 20-40 part, Radix Glycyrrhizae 15-30 part and SHANZHIZI 20-40 part are made.
2, the Chinese medicine of treatment chronic viral hepatitis B according to claim 1 is characterized in that: per 1000 parts of products are made for 30 parts by 40 parts of Herba Artemisiae Scopariaes, 30 parts of Herba Patriniae, 30 parts of Radix Gentianaes, 30 parts of Rhizoma Imperataes, 30 parts of the Radix Paeoniae Albas, 30 parts of Radix Et Rhizoma Rhei, 20 parts of Herba Ecliptaes, 20 parts of Radix Achyranthis Bidentataes, 30 parts of Radix Angelicae Sinensis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Rhizoma Curcumae, 30 parts of Radix Codonopsis, 20 parts of Carapax Trionycis, 50 parts of the Radixs Astragali, 30 parts of Fructus Crataegis, 15 parts of Squama Maniss, 30 parts of Pericarpium Citri Reticulataes, 20 parts of Radix Bupleuri, 20 parts in Poria, 30 parts of Herba Taraxaci, 30 parts of Rhizoma Polygonatis, 20 parts in Radix Glycyrrhizae and SHANZHIZI.
3, a kind of manufacture method for the treatment of the Chinese medicine of chronic viral hepatitis B is characterized in that: according to per 1000 parts of product Herba Artemisiae Scopariae 30-60 parts, Herba Patriniae 25-50 part, Radix Gentianae 20-40 part, Rhizoma Imperatae 20-40 part, Radix Paeoniae Alba 20-40 part, Radix Et Rhizoma Rhei 20-40 part, Herba Ecliptae 15-30 part, Radix Achyranthis Bidentatae 15-30 part, Radix Angelicae Sinensis 20-40 part, Rhizoma Atractylodis Macrocephalae 15-30 part, Rhizoma Curcumae 15-30 part, Radix Codonopsis 20-40 part, Carapax Trionycis 15-30 part, Radix Astragali 30-60 part, Fructus Crataegi 20-40 part, Squama Manis 10-20 part, Pericarpium Citri Reticulatae 20-40 part, Radix Bupleuri 15-30 part, Poria 15-30 part, Herba Taraxaci 20-40 part, Rhizoma Polygonati 20-40 part, the ratio of Radix Glycyrrhizae 15-30 part and SHANZHIZI 20-40 part is got raw material ready; To decoct with water 2 times after Herba Artemisiae Scopariae, Herba Patriniae, Radix Gentianae, SHANZHIZI, Rhizoma Polygonati and the Rhizoma Imperatae mixing, decocting time is 2 hours, 1.5 hours for the second time for the first time, and twice resulting decoction liquor merged, and is condensed into extractum; With wearing into smalls after Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Rhizoma Curcumae, Radix Et Rhizoma Rhei, Radix Codonopsis, the Radix Astragali, Radix Bupleuri, Squama Manis, Carapax Trionycis and the Radix Glycyrrhizae mixing, to mix with the resulting extractum of previous step then, dry back is being ground into fine powder; Herba Ecliptae, the Rhizoma Atractylodis Macrocephalae, Fructus Crataegi, Herba Taraxaci, the Radix Paeoniae Alba, Pericarpium Citri Reticulatae and Poria are decocted with water 2 times, produce behind the concentrated solution to mix according to the manufacture method of pill and make pill with resulting fine powder of last step.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610010241XA CN100411669C (en) | 2006-06-30 | 2006-06-30 | Chinese medicine for treating chronic virus hepatitis B and its producing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610010241XA CN100411669C (en) | 2006-06-30 | 2006-06-30 | Chinese medicine for treating chronic virus hepatitis B and its producing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1899529A true CN1899529A (en) | 2007-01-24 |
CN100411669C CN100411669C (en) | 2008-08-20 |
Family
ID=37655640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610010241XA Expired - Fee Related CN100411669C (en) | 2006-06-30 | 2006-06-30 | Chinese medicine for treating chronic virus hepatitis B and its producing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100411669C (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102085332A (en) * | 2011-01-13 | 2011-06-08 | 冯安华 | Medicament for treating early ascites due to cirrhosis |
CN101507779B (en) * | 2009-03-30 | 2011-06-08 | 席善根 | Chinese patent medicine for treating urgent, chronic viral hepatitis type B |
CN102727619A (en) * | 2012-06-14 | 2012-10-17 | 漳州片仔癀药业股份有限公司 | Medicinal composition treating fatty liver and preparations thereof |
CN105079578A (en) * | 2015-09-23 | 2015-11-25 | 黄名珠 | Medicine for treating hepatitis B |
CN106310111A (en) * | 2015-07-01 | 2017-01-11 | 熊虎 | Traditional Chinese medicine formula for treating viral hepatitis B |
CN107496736A (en) * | 2017-08-28 | 2017-12-22 | 段祖垒 | A kind of Chinese medicine powder and preparation method for treating damp-heat type chronic hepatitis B |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1413606A (en) * | 2001-10-24 | 2003-04-30 | 邓大勇 | Medicine for treatment of hepatitis |
CN1562160A (en) * | 2004-04-21 | 2005-01-12 | 金海清 | Composite medicine for treating hepatitis B complication |
-
2006
- 2006-06-30 CN CNB200610010241XA patent/CN100411669C/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101507779B (en) * | 2009-03-30 | 2011-06-08 | 席善根 | Chinese patent medicine for treating urgent, chronic viral hepatitis type B |
CN102085332A (en) * | 2011-01-13 | 2011-06-08 | 冯安华 | Medicament for treating early ascites due to cirrhosis |
CN102085332B (en) * | 2011-01-13 | 2012-08-22 | 冯安华 | Medicament for treating early ascites due to cirrhosis |
CN102727619A (en) * | 2012-06-14 | 2012-10-17 | 漳州片仔癀药业股份有限公司 | Medicinal composition treating fatty liver and preparations thereof |
CN106310111A (en) * | 2015-07-01 | 2017-01-11 | 熊虎 | Traditional Chinese medicine formula for treating viral hepatitis B |
CN105079578A (en) * | 2015-09-23 | 2015-11-25 | 黄名珠 | Medicine for treating hepatitis B |
CN107496736A (en) * | 2017-08-28 | 2017-12-22 | 段祖垒 | A kind of Chinese medicine powder and preparation method for treating damp-heat type chronic hepatitis B |
Also Published As
Publication number | Publication date |
---|---|
CN100411669C (en) | 2008-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101455791A (en) | Pure traditional Chinese medicine preparation for treating hyperlipemia | |
CN100411669C (en) | Chinese medicine for treating chronic virus hepatitis B and its producing method | |
CN100400094C (en) | Traditional Chinese medicine for treating hepatitis B and its preparing process | |
CN102423442B (en) | Double-component medicine for treating fatty liver and preparation method thereof | |
CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
CN101745092A (en) | Traditional Chinese medicine for treating infantile diarrhea | |
CN111729045A (en) | A Chinese medicinal composition with qi invigorating, superficial resistance consolidating and epidemic preventing effects, and its application in preventing and treating common cold or new coronary pneumonia | |
CN103100021A (en) | Pharmaceutical composition for tonifying spleen and stomach and method for preparing same | |
CN102309601A (en) | Traditional Chinese medicine (TCM) prescription for treating chloasma | |
CN101284113A (en) | Yin toxin Qingyuan pellet | |
CN1055223C (en) | Chinese medicine preparation for treatment of gastric ulcer, duodenal ulcer and gastritis | |
CN100512855C (en) | Method for preparing medication of gastrodia tuber and tuber of multiflower knotweed | |
CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
CN101513468A (en) | Oral medicament for treating herpes zoster | |
CN101850072A (en) | Chinese patent medicament for treating hepatitis B | |
CN101336976A (en) | Oral traditional Chinese medicine formulation for treating genital herpes and preparation method thereof | |
CN101352496A (en) | Traditional Chinese medicine for treating hepatitis | |
CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
CN102038825A (en) | Formula of traditional Chinese medicine for treating hyperthyroidism | |
CN103041018A (en) | Migraine treatment method using Chinese medicaments | |
CN106389824A (en) | Traditional Chinese medicine granules for promoting dispersing function of lung and preparation method thereof | |
CN101897923A (en) | Chinese medicinal powder for treating nighttime lumbago | |
CN1104903A (en) | Prepairing method for liver curing pill | |
CN105435129A (en) | Oral-taking traditional Chinese medicine for treating acne and preparation method thereof | |
CN101062302A (en) | Chinese medicinal preparation for hepatitis B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 Termination date: 20120630 |